House Committee of Reference Report
Committee on Health & Human Services
-
All text that will be removed from the bill will be indicated by strikethrough as follows:
-
This is text that is removed from law. -
Text that is added to a bill will be indicated by either all capitals or bold & italic as follows:
-
- This all capitals text would be added to law.
- This is bold & italic text that would be added to law.
March 24, 2026
After consideration on the merits, the Committee recommends the following:
HB26-1325 be amended as follows, and as so amended, be referred to the Committee on Appropriations with favorable recommendation:
Page 1, Line 1Amend printed bill, page 3, before line 26 insert:
Page 1, Line 2"(a) "Benefit-sharing plan" means an arrangement with
Page 1, Line 3Indigenous communities traditionally connected to the use of
Page 1, Line 4ibogaine or iboga that is intended to share in the benefits that
Page 1, Line 5arise from the research, therapeutic use, or commercialization
Page 1, Line 6of ibogaine or iboga. Benefits may include:
Page 1, Line 7(I) Financial benefit sharing;
Page 1, Line 8(II) Collaborative research or data sharing;
Page 1, Line 9(III) Conservation support for plant species and habitats;
Page 1, Line 10(IV) Community-identified development priorities;
Page 1, Line 11(V) Cultural or educational exchanges; and
Page 1, Line 12(VI) Utilizing a source for ibogaine that engages in
Page 1, Line 13benefit-sharing and ethical and sustainable cultivation
Page 1, Line 14practices.".
Page 1, Line 15Reletter succeeding paragraphs accordingly.
Page 1, Line 16Page 4, line 12, strike "enter into" and substitute "require".
Page 1, Line 17Page 5, line 17, strike "and".
Page 1, Line 18Page 5, line 19, strike "costs." and substitute "costs; and".
Page 1, Line 19Page 5, after line 19 insert:
Page 1, Line 20"(j) May collaborate and enter into agreements with
Page 1, Line 21other states, state agencies, federally recognized tribes, and
Page 1, Line 22public or private entities to participate in multi-state consortia
Page 2, Line 1or similar efforts, including the sharing of data, funding,
Page 2, Line 2research, clinical protocols, and regulatory best practices
Page 2, Line 3related to ibogaine and ibogaine-related therapies.".
Page 2, Line 4Page 6, strike lines 8 through 10 and substitute:
Page 2, Line 5"(b) Establish a benefit-sharing plan, which may be
Page 2, Line 6developed in consultation with Indigenous communities or their
Page 2, Line 7recognized governing institutions traditionally connected to
Page 2, Line 8ibogaine or iboga, that directly benefits those communities and
Page 2, Line 9shares in the benefits arising from research, therapeutic use, or
Page 2, Line 10commercialization of ibogaine or iboga. The benefit-sharing plan
Page 2, Line 11must include documentation of the sourcing of ibogaine or
Page 2, Line 12iboga.
Page 2, Line 13(c) In developing a benefit-sharing plan pursuant to this
Page 2, Line 14subsection (5), applicants may consider internationally
Page 2, Line 15recognized principles related to equitable benefit sharing that
Page 2, Line 16may arise from the use of resources and traditional
Page 2, Line 17knowledge.".
Page 2, Line 18Page 8, line 13, strike "title 12" and substitute "title 12, and the
Page 2, Line 19"Colorado Natural Medicine Code", article 50 of title 44.".
Page 2, Line 20Page 8, line 17, strike "(14)" and substitute "(14) (a)".
Page 2, Line 21Page 8, line 19, after "for" add "money damages in a civil
Page 2, Line 22malpractice action".
Page 2, Line 23Page 8, strike line 25 and substitute: "generally accepted standards
Page 2, Line 24of practice.
Page 2, Line 25Page 8, after line 25 insert:
Page 2, Line 26"(b) This subsection (14) does not apply to administrative
Page 2, Line 27proceedings.".
Page 2, Line 28Page 9, line 11, strike "regulated programs;" and substitute
Page 2, Line 29"administrative sessions pursuant to this article 170 and article
Page 2, Line 3050 of title 44;".
Page 2, Line 31Page 9, strike lines 16 through 20 and substitute "modification, or
Page 2, Line 32chemical conversion, except for ibogaine derived from a
Page 2, Line 33semi-synthetic process using the Tabernanthe iboga plant,
Page 2, Line 34Voacanga africana plant, or another source that is
Page 3, Line 1recommended by the board, pursuant to section 12-170-106, for
Page 3, Line 2use as a natural medicine and to the extent permitted by the
Page 3, Line 3state licensing authority, for use in administration sessions,
Page 3, Line 4pursuant to this article 170 and article 50 of title 44.".
Page 3, Line 5Page 9, after line 20 insert:
Page 3, Line 6"SECTION 4. In Colorado Revised Statutes, 12-170-105, amend
Page 3, Line 7(1)(a) introductory portion; and add (1)(a)(I.5) as follows:
Page 3, Line 812-170-105. Director powers and duties - prohibition - rules.
Page 3, Line 9(1) In addition to any other powers and duties granted or imposed
Page 3, Line 10on the director pursuant to this article 170 or by any other law, the
Page 3, Line 11director has the following powers and duties:
Page 3, Line 12(a) To promulgate adopt rules pursuant to section 12-20-204
Page 3, Line 13concerning the following subjects:
Page 3, Line 14(I.5) Requirements for the use and administration of
Page 3, Line 15ibogaine, including:
Page 3, Line 16(A) Requiring medical prescreening, which may include an
Page 3, Line 17electrocardiogram, blood tests, genetic tests, and any other
Page 3, Line 18medical test, the results of which may be used to help reduce the
Page 3, Line 19risks related to ibogaine administration for a participant;
Page 3, Line 20(B) Requiring continuous medical monitoring during an
Page 3, Line 21ibogaine administration session;
Page 3, Line 22(C) Requiring appropriate oversight by trained and
Page 3, Line 23experienced medical professionals during an ibogaine
Page 3, Line 24administration session; and
Page 3, Line 25(D) Requiring extended integration or aftercare, as
Page 3, Line 26appropriate, which may utilize referrals, medical and mental
Page 3, Line 27health professionals, and certified peer support specialists;".
Page 3, Line 28Renumber succeeding sections accordingly.
Page 3, Line 29Page 9, line 22, strike "and (4)(c);" and substitute "(4)(c), and (5)(f);".
Page 3, Line 30Page 12, strike lines 9 and 10 and substitute:
Page 3, Line 31"(4) (c) Except for the executive director of the state licensing
Page 3, Line 32authority, or the executive director's designee, Members of the board
Page 3, Line 33may".
Page 3, Line 34Page 12, after line 24 insert:
Page 3, Line 35"(5) The board shall make recommendations to the director and
Page 3, Line 36state licensing authority related to, but not limited to, the following areas:
Page 3, Line 37(f) The addition of other types of natural medicine to this article
Page 4, Line 1170 and article 50 of title 44 pursuant to section 12-170-104 (12)(b)(I),
Page 4, Line 2(12)(b)(II), or (12)(b)(III) based on available medical, psychological, and
Page 4, Line 3scientific studies, research, and other information related to the safety and
Page 4, Line 4efficacy of each natural medicine, and shall prioritize considering the
Page 4, Line 5addition of ibogaine pursuant to section 12-170-104 (12)(b)(II), to this
Page 4, Line 6article 170, and to article 50 of title 44, including additional genera
Page 4, Line 7or species of plants that may be cultivated and manufactured
Page 4, Line 8to create semi-synthetic ibogaine;".
Page 4, Line 9Page 13, strike line 1 and substitute: "(3) (a) A facilitator is not
Page 4, Line 10liable for money damages in a civil malpractice action for a
Page 4, Line 11physical or".
Page 4, Line 12Page 13, strike line 7 and substitute "generally accepted standards
Page 4, Line 13of practice.".
Page 4, Line 14Page 13, after line 7 insert:
Page 4, Line 15"(b) This subsection (3) does not apply to administrative
Page 4, Line 16proceedings.".
Page 4, Line 17Page 13, strike lines 18 through 21 and substitute:
Page 4, Line 18"(a) Applicants who participate in the pilot program to
Page 4, Line 19administer ibogaine pursuant to section 27-60-207;".
Page 4, Line 20Page 13, after line 25 insert:
Page 4, Line 21"SECTION 8. In Colorado Revised Statutes, 44-50-202, amend
Page 4, Line 22(1)(a) as follows:
Page 4, Line 2344-50-202. Powers and duties of state licensing authority -
Page 4, Line 24report - rules.
Page 4, Line 25(1) The state licensing authority shall:
Page 4, Line 26(a) Beginning on or before December 31, 2024, grant or refuse
Page 4, Line 27state licenses for the cultivation, manufacturing, testing, storage,
Page 4, Line 28distribution, transport, transfer, and dispensation of regulated natural
Page 4, Line 29medicine or regulated natural medicine product; suspend, fine, restrict, or
Page 4, Line 30revoke such the licenses, whether active, expired, or surrendered, upon
Page 4, Line 31a violation of this article 50 or a rule promulgated adopted pursuant to
Page 4, Line 32this article 50; and impose any penalty authorized by this article 50 or a
Page 4, Line 33rule promulgated adopted pursuant to this article 50. The state licensing
Page 4, Line 34authority may take any action with respect to a registration or permit
Page 4, Line 35pursuant to this article 50 as it may with respect to a license issued
Page 4, Line 36pursuant to this article 50, in accordance with the procedures established
Page 5, Line 1pursuant to this article 50.
Page 5, Line 2(I) The incorporation of additional natural medicines, as
Page 5, Line 3recommended by the board and approved by the director and
Page 5, Line 4executive director of the state licensing authority, is subject to
Page 5, Line 5available funding to cover the direct and indirect costs of
Page 5, Line 6administering this article 50 . The state licensing authority is
Page 5, Line 7not required to incorporate additional natural medicines if
Page 5, Line 8there is not sufficient funding to finance program
Page 5, Line 9administration.
Page 5, Line 10(II) Once sufficient funding is secured for program
Page 5, Line 11implementation, the state licensing authority, in consultation
Page 5, Line 12with the board, the department of regulatory agencies, the
Page 5, Line 13behavioral health administration, and the department of public
Page 5, Line 14health and environment, shall determine the program scope for
Page 5, Line 15implementation.".
Page 5, Line 16Renumber succeeding sections accordingly.
Page 5, Line 17Page 13, line 26 and 27, strike "amend (2)(r) and (2)(s)(III); and add
Page 5, Line 18(2)(t)," and substitute "add".
Page 5, Line 19Page 13, line 27, strike "and (5)" and substitute "(5), and (6)".
Page 5, Line 20Page 14, strike lines 2 through 27.
Page 5, Line 21Page 15, strike lines 1 through 6.
Page 5, Line 22Page 15, line 9 and 10, strike "administer or dispense." and substitute
Page 5, Line 23"cultivate, manufacture, test, or dispense.".
Page 5, Line 24Page 15, strike lines 11 through 16 and substitute:
Page 5, Line 25"(5) (a) A licensee seeking to cultivate, manufacture, test,
Page 5, Line 26dispense, or administer ibogaine shall, in consultation with
Page 5, Line 27Indigenous communities or their authorized representative,
Page 5, Line 28establish a benefit-sharing plan that directly benefits those
Page 5, Line 29communities. A licensee may use or rely on a third party for
Page 5, Line 30consultation.
Page 5, Line 31(b) A licensee shall maintain documentation
Page 5, Line 32demonstrating the consultation process and the development of
Page 5, Line 33the benefit-sharing plan and make the documentation publicly
Page 5, Line 34available upon request.
Page 5, Line 35(6) Nothing in this section shall be interpreted to require
Page 6, Line 1Indigenous communities to disclose or share traditional
Page 6, Line 2knowledge, ceremonial practices, or cultural expressions.".